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A B S T R A C T
The cytoplasmic dynein motor complex transports essential signals and organelles from the cell periphery to the
perinuclear region, hence is critical for the survival and function of highly polarized cells such as neurons.
Dynein Light Chain Roadblock-Type 1 (DYNLRB1) is thought to be an accessory subunit required for specific
cargos, but here we show that it is essential for general dynein-mediated transport and sensory neuron survival.
Homozygous Dynlrb1 null mice are not viable and die during early embryonic development. Furthermore,
heterozygous or adult knockdown animals display reduced neuronal growth, and selective depletion of Dynlrb1
in proprioceptive neurons compromises their survival. Conditional depletion of Dynlrb1 in sensory neurons
causes deficits in several signaling pathways, including β-catenin subcellular localization, and a severe im-
pairment in the axonal transport of both lysosomes and retrograde signaling endosomes. Hence, DYNLRB1 is an
essential component of the dynein complex, and given dynein's critical functions in neuronal physiology,
DYNLRB1 could have a prominent role in the etiology of human neurodegenerative diseases.
1. Introduction
Molecular motors perform a critical function in eukaryotic cells,
ensuring the anterograde (kinesins) and retrograde (dyneins) transport
of cargoes, organelles and cellular components. Dynein motors are di-
vided into two major classes: axonemal dyneins, which are involved in
ciliary and flagellar movement, and cytoplasmic dyneins, minus-end
microtubule molecular motors involved in vesicular transport, cell
migration, cell division and maintenance of Golgi integrity (Hirokawa
et al., 2010; Kardon and Vale, 2009; Reck-Peterson et al., 2018). Cy-
toplasmic dynein is the main retrograde motor in all eukaryotic cells
and is particularly important in highly polarized cells such as neurons,
where it carries essential signals and organelles from the periphery to
the cell body (Terenzio et al., 2017). Cytoplasmic dynein consists of two
heavy chains (HC) associated with intermediate chains (IC), which
provide direct binding to dynactin (Karki and Holzbaur, 1995; King
et al., 2003; Siglin et al., 2013), four light intermediate chains (LIC) and
several light chains (LC) (Reck-Peterson et al., 2018). There are three
families of dynein light chains, LC7/road-block, LC8 and Tctx1/rp3, the
latter playing a role in the direct binding of cargoes to the dynein motor
complex (Olenick and Holzbaur, 2019; Reck-Peterson et al., 2018; Tai
et al., 1999).
Dynein Light Chain Roadblock-Type 1 (DYNLRB1), also known as
Km23, and DNLC2A (Jiang et al., 2001; Tang, 2002), was first identified
in Drosophila during a genetic screen for axonal transport mutants
(Bowman et al., 1999). Roadblock mutants exhibited defects in in-
tracellular transport, including intra-axonal accumulation of synaptic
cargoes, severe axonal degeneration and aberrant chromosome segre-
gation (Bowman et al., 1999). DYNLRB protein sequence is highly
conserved among different species; with two isoforms, DYNLRB1 and
DYNLRB2, sharing 98% sequence similarity in mammals (Susalka et al.,
2002). Mammalian DYNLRB1 has been studied mainly as an adaptor
linking specific modules to the dynein complex, including SMAD2
complexes activated by TGFβ receptors (Jin et al., 2013, 2012, 2009,
2007, 2005; Tang, 2002) and Rab6 or N-acetyl-D-glucosamine kinase
(NAGK) for interactions with the Golgi compartment (Islam et al.,
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2015b, 2015a; Wanschers et al., 2008).
In previous work, we identified a role for the dynein complex in
regulating axon growth rates (Perry et al., 2016; Rishal et al., 2012). A
screen of all dynein accessory subunits now shows that knockdown of
Dynlrb1 reduces neurite outgrowth in cultured sensory neurons. Sur-
prisingly, a complete knockout of Dynlrb1 was found to be embryonic
lethal, suggesting the existence of non-redundant functions between
DYNLRB1 and DYNLRB2. Conditional knockout or acute knockdown of
Dynlrb1 compromised survival of proprioceptive neurons, together with
changes in subcellular localization of transported cargos, and major
impairments in the axonal transport of lysosomes and retrograde sig-
naling endosomes. Thus, DYNLRB1 is an essential component of the
dynein complex, and the conditional allele described here enables se-
lective targeting of dynein functions.
2. Results
2.1. Depletion of Dynlrb1 impairs neurite outgrowth in cultured DRG
neurons
We performed an siRNA screen in cultured dorsal root ganglion
(DRG) neurons to investigate the effects of downregulating individual
dynein subunits on axonal growth. Knockdowns of Dync1i2, Dync1li2,
Dynlrb1 and Dctn6 reduced the extent of axon outgrowth in cultured
DRG neurons (Fig. 1A), with Dynlrb1 knockdown providing the most
robust effect (Fig. 1A, B). We then sought to validate this finding in a
knockout mouse model for Dynlrb1 generated by the European Condi-
tional Mouse Mutagenesis Program (EUCOMM) as part of the Interna-
tional Mouse Knockout Consortium. The gene targeted Dynlrb1tm1a(EU-
COMM)Wtsi allele, hereafter referred to as Dynlrbtm1a, results in a complete
knockout of Dynlrb1 with concomitant expression of β-galactosidase
from the same locus; this allele also allows the subsequent generation of























































































































Fig. 1. Depletion of Dynlrb1 reduces axon
outgrowth in DRG neurons.
A: siRNA screen for effects of dynein com-
plex subunits on neuronal growth
(n > 100 cells for each). Positive hits
(Dync1i2, Dync1li2, Dynlrb1 and Dctn6)
were validated in at least three in-
dependent experiments (n > 500 cells
each). ** p < .01, and *** p < .001
(Student's t-test and one-way ANOVA).
B: Fluorescence images of cultured DRG
neurons from adult Thy1-YFP mice trans-
fected with either siControl or siDynlrb1.
Neurons were re-plated 24 h after siRNA
transfection, and images were acquired
48 h after re-plating. YFP signal in green.
Scale bar, 200 μm.
C: Fluorescent images of cultured DRG
neurons from wild type Thy1-YFP mice and
Thy1-YFP- Dynlrbtm1a/+ mice (YFP signal in
green). Cells were imaged every hour for a
period of 48 h. Scale bar, 100 μm.
D: Quantification of the time-lapse imaging
experiment described in C. Mean ± SEM,
*** p < .001, n = 3, two-way ANOVA.
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recombinase (Supplementary Fig. 1A)(Skarnes et al., 2011). Homo-
zygous complete knockout mice (Dynlrbtm1a/tm1a) were not viable, and
analyses of early pregnancies showed loss of homozygous null embryos
before E9.5, while heterozygous animals were viable. The β-galactosi-
dase expression pattern in heterozygous mice showed that DYNLRB1
was highly expressed in DRGs of E12.5 mouse embryos (Supplementary
Fig. 1B). We then crossed (Dynlrbtm1a/+) heterozygous mice with Thy1-
yellow fluorescent protein (YFP) mice (Feng et al., 2000) to allow live
imaging of DRG neuron growth in culture. Similarly to Dynlrb1
knockdown neurons (Fig. 1A, B), Thy1-YFP- Dynlrbtm1a/+ DRG neurons
had significantly reduced axon outgrowth compared to littermate
controls (Fig. 1C, D).
2.2. Dynlrb1 deletion affects survival of proprioceptive neurons
We proceeded to cross Dynlrbtm1a/+ heterozygotes with mice ex-
pressing the Flp recombinase (Farley et al., 2000) to recombine the FRT
sites, thereby removing the LacZ sequence (Sadowski, 1995). This
generated a conditional allele, Dynlrbtm1c in which LoxP sites flank exon
3 of Dynlrb1 (Supplementary Fig. 1A). Dynlrbtm1c mice were then
crossed with a RNX3-Cre driver line (Levanon et al., 2011), to examine
the effect of Dynlrb1 deletion in proprioceptive sensory neurons. In
contrast to the full knockout, RNX3-Dynlrbtm1d/tm1d, hereafter referred
to as RNX3-Dynlrb1−/−, mice were viable to adulthood. However, these
mice displayed abnormal hind limb posture (Fig. 2A), and an un-
coordinated walking pattern with abdomen posture close to the ground
(Supplementary movie S1). A battery of tests of motor activity and
proprioception showed that RNX3-Dynlrb1−/− mice were unable to
balance themselves in the rotarod (Fig. 2B) and exhibited an abnormal
walking pattern in the catwalk (Fig. 2C, D). There was no difference
between genotypes in basal motor activity (Supplementary Fig. 2A), but
RNX3-Dynlrb1−/− mice displayed lower speed and covered less dis-
tance than their wild type counterparts in the open field (Supplemen-
tary Fig. 2B-D). Overall, these tests reveal a strong impairment of
proprioception in adult RNX3-Dynlrb1−/− mice.
To understand the mechanistic basis of this impairment, we per-
formed histological analyses on RNX3-Dynlrb1−/− mice. There was no
difference between genotypes in neuromuscular junction size or num-
bers (Supplementary Fig. 2E, F), and in total (Tuj1 positive) or noci-
ceptive (CGRP positive) skin innervation (Supplementary Fig. 2G, H).
However, the number of proprioceptive NFH-positive neurons in DRG
ganglia was greatly reduced in RNX3-Dynlrb1−/− mice (Fig. 2E, F),
while CGRP-positive nociceptive neuron numbers did not differ be-
tween genotypes (Fig. 2E, F). These data reaffirm the specificity of the
RNX3-Cre driver and indicate that the proprioceptive impairment ob-
served in RNX3-Dynlrb1−/− mice is due to a loss of this class of sensory
neurons.
2.3. Acute viral-mediated knockdown of Dynlrb1 causes motor-balance
defects in vivo
The RNX3-Cre driver is activated early in development. In order to
determine whether Dynlrb1 deletion has similar effects upon acute de-
pletion in adult proprioceptive neurons, wild type mice were injected
intrathecally with adeno-associated virus (AAV) harboring an shRNA
against Dynlrb1 or an shControl sequence. We used AAV serotype 9 for
neuronal-specific knockdown (Naso et al., 2017; Snyder et al., 2011),
and observed transduction rates of 25–35% in DRG ganglia (Fig. 3A, B).
Efficiency of the knockdown was found to be in the range of 40% de-
crease in Dynlrb1 mRNA levels in cultured DRG (Fig. 3C). 32 days after
the injection, mice transduced with AAV-shDynlrb1 developed motor
problems and abnormal hind limb posture (Fig. 3D). AAV-shDynlrb1
transduced mice showed significant impairment in rotarod and catwalk
analyses when compared with AAV-shControl transduced animals
(Fig. 3E-G). Overall these data show that Dynlrb1 is critical for adult
sensory neurons and its depletion by knockdown recapitulates the
phenotype observed in the RNX3-Dynlrb1−/− mice.
2.4. Gene expression changes in Dynlrbtm1a/+ DRG neurons
We then sought to obtain insights on the physiological role(s) of
DYNLRB1. Since complete depletion of DYNLRB1 is lethal, we focused
on Dynlrbtm1a/+ DRG neurons, which are viable and display reduced
neurite outgrowth. RNA-seq of Dynlrbtm1a/+ versus wild type DRG
neurons at 12, 24 and 48 h in culture showed almost no differences
between the two genotypes at 12 and 24 h, while significant differences
were observed at 48 h (Fig. 4A, B, Supplementary Table S1). Bioin-
formatic analyses of the differentially expressed genes dataset revealed
changes in a number of signaling and transcriptional pathways, in-
cluding the canonical Wnt – β-catenin pathway (Fig. 4B, C, Supple-
mentary Table S2). Interestingly, direct interaction between a Dynein
intermediate chain and β-catenin has been shown in epithelial cells
(Ligon et al., 2001), where the complex tethers microtubules at ad-
herens junctions. Thus, DYNLRB1 might be part of a dynein complex
carrying β-catenin from the periphery to the nucleus. Indeed, β-catenin
nuclear accumulation at 48 h in culture is reduced in Dynlrbtm1a/+ DRG
neurons compared to their wild type littermates (Fig. 4D, E).
2.5. Depletion of Dynlrb1 has significant effects on axonal retrograde
transport
The broad spectrum of gene expression changes in Dynlrbtm1a/+
DRG neurons argues for a general role of this subunit in the dynein
complex. We therefore investigated the effect of DYNLRB1 depletion on
dynein-mediated axonal retrograde transport, using acute depletion of
Dynlrb1 in culture to circumvent the loss of neurons observed in RNX3-
Dynlrb1−/− mice. To this end, we transduced Dynlrbtm1c/tm1c DRG
neurons with Adenovirus 5 (Ad5) expressing a Cre-GFP, to induce re-
combination of the Dynlrbtm1c allele to Dynlrbtm1d in infected cells. We
first optimized the transduction protocol using neurons from the Ai9
mouse (Madisen et al., 2010), which expresses td-Tomato under the
control of a LoxP-flanked STOP cassette and showed that 72 h of in-
cubation with Ad5 Cre-GFP are sufficient to express the Cre and trigger
the recombination of LoxP sites in cultured DRG neurons (Supple-
mentary Fig. 3A, B). We then tracked axonal retrograde transport of
acidic organelles, including lysosomes, late endosomes and autopha-
gosomes in Ad5-Cre: Dynlrbtm1d/tm1d DRG neurons using Lysotracker
Red. Indeed, Ad5-Cre: Dynlrbtm1d/tm1d transduced neurons 96 h in cul-
ture showed a significant impairment of axonal retrograde transport of
these organelles, both in terms of velocity of individual carriers and the
overall fraction of moving carriers (Fig. 5A-C).
We further examined transport properties using a marker for neu-
rotrophin signaling endosomes, the binding fragment of tetanus neu-
rotoxin (HCT) fragment (Deinhardt et al., 2006; Lalli and Schiavo,
2002). Whilst we could not detect any significant differences in the
rates of transport of HCT-positive retrograde axonal carriers in Ad5-Cre:
Dynlrbtm1d/tm1d neurons (Fig. 5D, E), the percentage of stationary car-
riers was significantly increased (Fig. 5F), as was also found for Lyso-
tracker Red-positive organelles (Fig. 5C). Thus, depletion of DynlRb1
has significant effects on retrograde transport of a broad spectrum of
dynein cargos.
3. Discussion
The dynein complex has essential roles in all multicellular organ-
isms, most prominently in long distance axonal transport in neurons.
Studies on specific roles of dynein carriers have suffered from a lack of
appropriate mouse models, since homozygous deletion or mutation of
Dync1h1 results in early embryonic death (Hafezparast et al., 2003;
Harada et al., 1998). We have characterized a new conditional
knockout model for the DYNLRB1 subunit of dynein and use this model
to show that DYNLRB1 is required for retrograde axonal transport of a


















































































































Fig. 2. Conditional Dynlrb1 depletion affects survival of proprioceptive neurons in vivo.
A: Abnormal clenched hind-limb phenotype in RNX-Dynlrb1−/− mice suspended from the tail, compared to the typical limb extension of wild type animals.
B: Rotarod test (acceleration set at 20 rpm in 240 s) showing that RNX-Dynlrb1−/− mice are unable to balance themselves on the rod. Mean ± SEM, *** p < .001,
n > 6 mice per genotype, two-way ANOVA.
C: Representative catwalk gait traces for wild type and RNX-Dynlrb1−/− mice. The position of the paws are shown in different colors as indicated, RF - right front, RH
- right hind, LF - left front, LH - left hind.
D: Step sequence regularity index and Paw stands from the catwalk gait analyses of C shows impairment in RNX-Dynlrb1−/− mice compared to wild type.
Mean ± SEM, * p < .05 *** p < .001, n > 6 mice per genotype, one-way ANOVA followed by Tukey's HSD post hoc correction for multiple comparisons.
E: Representative DRG ganglia sections from wild type and RNX-Dynlrb1−/− mice, stained with either NFH (green) for proprioceptive neurons or CGRP (red) for
nociceptors. Scale bar, 50 μm.
F: Quantification of NFH and CGRP positive neurons from the experiment described in G. Mean ± SEM, * p < .05, n = 3 per genotype, unpaired t-test.
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broad spectrum of cargos in sensory axons, as well as for neuronal
survival. These findings were surprising given the notion that DYNRLB1
should function mainly as a binding adaptor for TGFβ signaling com-
plexes and other specific cargos (Jin et al., 2013, 2012, 2009, 2007,
2005; Tang, 2002), whereas our data suggests that DYNLRB1 is essen-
tial for dynein-mediated axonal transport of lysosomes, late endosomes
and signaling endosomes.
The hindlimb proprioception phenotype observed in both RNX3-
Dynlrb1−/− mice and Dynlrb1 viral-mediated knockdown is highly re-
miniscent of dynein heavy chain mutant models, such as Dync1h1Loa
and Dync1h1Cra1 (Dupuis et al., 2009; Hafezparast et al., 2003). Both
models show deficits in endosomal axonal retrograde transport
(Hafezparast et al., 2003) and proprioception (Dupuis et al., 2009;
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knockdown of Dynlrb1. In addition, depletion of Roadblock in Drosophila
was described to cause defects in intra-axonal accumulation of cargoes
and severe axonal degeneration (Bowman et al., 1999). The distal en-
richment of axonal accumulations observed in Roadblock mutants was
suggested to arise from axonal transport deficits originating at the sy-
napse (Bowman et al., 1999). Moreover, incorporation of DYNLRB1 and
DYNLRB2 into the Dynein-2 complex, which drives retrograde protein
trafficking in primary cilia, was recently shown to be crucial for dynein-
2 transport function (Tsurumi et al., 2019). While the precise me-
chanism by which dynein activity is impaired upon loss of DYNLRB1 is
yet to be determined, it is interesting to note that this subunit can bind
directly to core components of the dynein complex such as the inter-
mediate chains DYNCI1 and DYNCI2 (IC74–1 and IC74–2) (Susalka
et al., 2002). The latter directly associate with the dynactin complex,
which facilitates interactions of numerous cargos with the main motor
complex, and expedites processive transport along microtubules (Karki
and Holzbaur, 1995; Reck-Peterson et al., 2018).
Our findings show that Dynlrb1 is critical not only for embryonic
development, but also for maintenance of sensory neurons in adult-
hood. Deficits in dynein functions have been implicated in the patho-
genesis of neurodegenerative diseases such as Amyotrophic Lateral
Sclerosis (ALS) (Bilsland et al., 2010; Gershoni-Emek et al., 2016;
Hoang et al., 2017; Schiavo et al., 2013; Teuling et al., 2008; Xie et al.,
2015), and an increasing number of human neurodegenerative
pathologies have been linked to mutations of dynein complex genes
(Terenzio et al., 2018a). In addition, mutations and/or disruption of the
function of the dynactin complex have been shown to be connected to
motor neuron degeneration and ALS (Kuźma-Kozakiewicz et al., 2013;
LaMonte et al., 2002; Moore et al., 2009; Münch et al., 2004; Puls et al.,
2003). The new mouse model described herein will expand the options
for studying such roles of dynein, using conditional targeting of
Dynlrb1 for both temporal and tissue/cell type specificity in such stu-
dies in vivo.
4. Materials and methods
Key resource table
Reagent or resource Source Identifier
Antibodies
NFH (Chicken) Millipore Cat Number:
AB144P
Tuj1 (Rabbit) Covance RRID: AB_2313773
CGRP (Goat) Abcam RRID: AB_725807
β-catenin (Mouse) A. Ben-Ze’ev lab (Johnson
et al., 1993; Simcha et al.,
1998)
Clone 5H10
GFP (Rabbit) MBL International RRID:AB_10597267
Alexa Fluor 488 secondary
antibody (Donkey anti-
rabbit)
Thermo Fisher Scientific RRID: AB_2556546
Alexa Fluor 546 secondary
antibody (Donkey anti-
rabbit)
Thermo Fisher Scientific RRID: AB_2534016
Alexa Fluor 546 secondary
antibody (Donkey anti-
goat)
Thermo Fisher Scientific RRID: AB_2534103
DAPI (4.6-diamino-2-pheno-
lindol dihydrochloride)
Thermo Fisher Scientific RRID: AB_2629482















Mouse/FLP1eR - 129 /
129S4/SvJaeSor-Gt(RO-
SA)26Sortm1(FLP1)Dym/J
(Farley et al., 2000) N/A
Mouse/Ai9 (Madisen et al., 2010) N/A
Mouse/R26LacZ/Runx3Cre (Levanon et al., 2011) N/A
siRNA screen Dharmacon smartpools
Catalog number Gene symbol Locus ID Accession
D-001210-02 Non-targeting siRNA N/A N/A
M-043143-01 Dync1i1 13426 NM_010063
M-043171-01 Dync1i2 13427 NM_010064
M-051314-01 Dync1li1 235661 NM_146229
M-061580-01 Dync1li2 234663 NM_001013380
M-062961-01 Dync2li1 213575 NM_172256
M-055779-01 Dynlt1 21648 NM_009342
M-059901-01 Dynlt3 67117 NM_025975
M-044820-01 Dynlrb1 67068 NM_025947
M-050822-01 Dynlrb2 75465 NM_029297
M-063157-01 Dynll1 56455 NM_019682
M-059592-01 Dynll2 68097 NM_026556
M-044821-00 DCTN1 13191 NM_007835
M-056851-00 DCTN2 69654 NM_027151
M-063002-00 DCTN3 53598 NM_016890
M-063074-00 DCTN4 67665 NM_026302
M-063270-00 DCTN5 59288 NM_021608
M-047876-00 DCTN6 22428 NM_011722
M-049777-00 ACTR10 56444 NM_019785
Contact for reagent and resources sharing
Further information and requests for resources and reagents should
be directed to Marco Terenzio (marco.terenzio@oist.jp).
Experimental model and subject details
Animal subjects
All animal procedures were approved by the IACUC of the
Weizmann Institute of Science. The knockout mouse model for Dynlrb1
was generated by the European Conditional Mouse Mutagenesis
Fig. 3. Characterization of Dynlrb1 knockdown in the DRG in vivo.
A: DRG ganglia sections from mice transduced with either AAV9-shControl or AAV9-shDynlrb1. AAV9 infected cells express the Venus reporter (green). Sensory
neurons are labeled with β3 tubulin (red). Scale bar, 50 μm.
B: Percentage of GFP-positive neurons normalized to β3 tubulin-positive neurons in DRG sections of the experiment described in A.
C: Quantitative PCRs on RNA extracted from DRG neuron cultures transduced with AAV9-shControl or AAV9-shDynlrb1 for 7 days. AAV9-shDynlrb1 transduced
neurons showed 40% reduction of Dynlrb1 mRNA compared to shControl. Mean ± SEM, *** p < .001, n = 6, unpaired t-test.
D: Tail suspension reveals a clenched hind limb phenotype in mice transduced with AAV9-shDynlrb1 compared to AAV9-shControl-treated animals.
E: Rotarod tests (acceleration set at 20 rpm in 240 s) on mice transduced as shown, 32 days after viral injection. AAV9-shDynlrb1-transduced mice show significantly
reduced performance in the test. Mean ± SEM, * p < .05, ** p < .01, *** p < .001, n > 11 mice per group, two-way ANOVA.
F: Representative traces from catwalk gait analyses on mice transduced as described in (e). The position of the paws are shown in different colors as indicated, RF –
right front, RH - right hind, LF - left front, LH - left hind.
G: Catwalk analysis of experiment described in C. The step sequence regularity index as well as the duration of the paw stands are impaired for both front paws in
mice transduced with AAV9-shDynlrb1. Mean ± SEM, * p < .05, *** p < .001, n > 11 mice per group, unpaired t-test.
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Fig. 4. RNA-seq of cultured Dynlrbtm1a/+ DRG neurons highlights signaling deficits.
A: Bar charts representing the numbers of differentially expressed genes (contrast analysis in EdgeR, FDR < 0.1) in wild type and Dynlrbtm1a/+ DRG neurons at the
indicated time points in culture.
B: Heat map representing the differential expressed genes in wild type and Dynlrbtm1a/+ mice at 48 h in culture (Log10(FPKM)).
C: Ingenuity pathway analyses on the 48 h differentially expressed genes dataset, ranked by –log(p values). The Wnt – β-catenin pathway (highlighted in red) was
selected for further validation.
D: Representative cell bodies of wild type and Dynlrbtm1a/+ DRG neurons cultured for 48 h before immunostaining as shown. Scale bar, 20 μm.
E: Quantification of nuclear versus cytoplasmic β-catenin in the experiment described in C. Mean ± SEM, * p < .05 ** p < .01, n > 3 mice per genotype, one-
way ANOVA followed by Tukey's HSD post hoc correction for multiple comparisons.




















































































































































































































































Fig. 5. Axonal retrograde transport deficits after Dynlrb1 depletion.
A: Representative kymographs of Lysotracker Red tracking on wild type and Dynlrbtm1c/tm1c DRG neurons transduced for 96 h in culture as indicated (Ad5-Cre,
Adenovirus5 expressing Cre-GFP) for 96 h. Diagonal lines indicate retrogradely moving carriers.
B: Velocity distributions from the experiment shown in A, Mean ± SEM, n > 32 axons per group over 3 independent biological repeats.
C: Fraction of moving versus stationary carriers in the experiment described in A. Mean ± SEM, *** p < .001, n > 32 axons per group over 3 independent
biological repeats, two-way ANOVA.
D: Representative kymographs of TeNT HCT tracking on wild type and Dynlrbtm1c/tm1c DRG neurons transduced for 96 h in culture as indicated.
E: Velocity distributions from the experiment shown in (d). Mean ± SEM, n > 36 axons per group over 3 independent biological repeats.
F: Fraction of moving versus stationary carriers in the experiment described in D. Mean ± SEM, ** p < .01, n > 36 axons per group over 3 independent biological
repeats, two-way ANOVA.
M. Terenzio, et al. Neurobiology of Disease 140 (2020) 104816
8
Program (EUCOMM) as part of the International Mouse Knockout
Consortium (IKMC, allele: Dynlrb1tm1a(EUCOMM)Wtsi) using a KO first
targeting vector (MPGS8001_A_B08, IKMC Project 25156) (Skarnes
et al., 2011). All mouse strains used were bred and maintained at the
Veterinary Resource Department of the Weizmann Institute of Science.
For live imaging of DRG outgrowth (Fig. 1A-D) C57BL/6J YFP16 mouse
were used (Feng et al., 2000). All control mice were age-, sex- matched
littermates. For testing Adenovirus5 Cre-GFP infectivity Ai9 mice were
used (Madisen et al., 2010). Mice utilized for behavioral experiments
were kept at 24.0±0.5°C in a humidity-controlled room under a 12-h
light–dark cycle with free access to food and water. Experiments were
carried out on 2-6 months old male mice, unless specified otherwise.
Generation of the Dynlrbtm1c and RNX3- Dynlrbtm1d/tm1d lines
The Dynlrb1 mice were acquired from the International Mouse
Knockout Consortium (IKMC, allele: Dynlrb1tm1a(EUCOMM)Wtsi).The gene
targeted Dynlrb1tm1a(EUCOMM)Wtsi allele, hereafter referred to as
Dynlrbtm1a, results in a complete knockout of Dynlrb1 with concomitant
expression of β-galactosidase from the same locus; this allele also allows
the subsequent generation of a floxed conditional allele (Dynlrbtm1c)
upon application of the Flp recombinase (Skarnes et al., 2011).
Dynlrbtm1a/+ heterozygous mice were crossed with a mouse harboring
the Flp recombinase in all tissues (FLP1eR - 129/129S4/SvJaeSor-Gt
(ROSA)26Sortm1(FLP1)Dym/J) (Farley et al., 2000), which was provided
by the veterinary services of the Weizmann Institute of Science to re-
combine the FRT sites and so remove the LacZ sequence, generating a
conditional allele, Dynlrbtm1c in which LoxP sites flank a likely critical
exon, exon 3, of Dynlrb1 ((Skarnes et al., 2011), Suppl. Fig. 1A). We
further crossed the Dynlrbtm1c mice with the proprioceptive Cre-driver
R26LacZ/Runx3Cre (Levanon et al., 2011) to generate the RNX3-
Dynlrbtm1d/tm1d line, which we refer to in the text as RNX3-Dynlrb1




Adult mice DRGs were dissociated with 100 U of papain followed by
1 mg/ml collagenase-II and 1.2 mg/ml dispase. The ganglia were then
triturated in HBSS, 10 mM Glucose, and 5 mM HEPES (pH 7.35).
Neurons were recovered through Percoll, plated on laminin, and grown
in F12 medium (ThermoFisher Scientific) as previously described (Ben-
Yaakov et al., 2012; Hanz et al., 2003; Perlson et al., 2005).
siRNA screen
Adult C57BL/6 YFP16 mouse DRG (Feng et al., 2000) were dis-
sociated and an siRNA screen was conducted as previously described
(Rishal et al., 2012). Briefly, mouse siGenome smart pools (Dharmacon)
were used for transfection of neuronal cultures two hours after plating,
using DharmaFect 4 as the transfection reagent. 24 hours after siRNA
transfection the neurons were plated in new poly-L-lysine and Laminin
treated glass bottom 96 well plates at the same density (80,000-100,000
cells per well) and imaged 72 h after transfection. Images were cap-
tured at X10 magnification on ImageXpress Micro (Molecular Devices)
and analyzed using the Metamorph software (Molecular Devices). The
total outgrowth parameter was considered, defined as the sum of
lengths of all processes and branches per cell. Statistical analyses were
carried out with Student’s t-test and One Way ANOVA using the sta-
tistical software GraphPad Prism.
Growth rate analysis
Adult C57BL/6J YFP16 mouse DRG (Feng et al., 2000) were dis-
sociated as previously described (Rishal et al., 2012), and neurons were
plated on MatTek glass bottom dishes (MatTek corporation). YFP6 -
Wild type and YFP16-Dynlrb1+/- neurons were imaged at 1h intervals
in a Fluoview (FV10i, Olympus) automated confocal laser-scanning
microscope with built-in incubator chamber. Neuronal morphology was
subsequently quantified using the Metamorph sofware (Molecular De-
vices). The total outgrowth parameter was considered, defined as the
sum of lengths of all processes and branches per cell. Statistical analyses
were carried out with a Two-way ANOVA test using the statistical
software GraphPad Prism.
Adenovirus infection of DRG neurons from Ai9 mice
The efficiency transduction of adenovirus 5 Cre-GFP (Ad5 Cre-GFP)
and the efficiency of the viral Cre were tested by infecting DRG neurons
with Ad5 Cre-GFP at a multiplicity of infection (MOI) of 100. DRG
neurons from Ai9 mice (Madisen et al., 2010) were dissected as pre-
viously described. The Ai9 Cre reporter mice harbour a LoxP-flanked
STOP cassette preventing transcription of a CAG promoter-driven red
fluorescent protein variant (td-Tomato). The virus was added directly
into the F12 culture medium immediately after plating. Infected cul-
tures were then incubated at 37°C for 48 and 72 h. After each time-
point, neurons were washed in PBS, fixed in 4% PFA in PBS for 30 min
and immunostained with an α-GFP antibody (1:1000) as previously
described. Coverslips were then mounted with Flouromount-GTM and
imaged using the ImageXpress (Molecular Devices) automated micro-
scope at 10X magnification or using a confocal laser-scanning micro-
scope (Olympus FV1000, 60x oil-immersion objective Olympus UP-
LSAPO - NA 1.35). Image quantification was performed using the
proprietary software Metamorph (Molecular Devices). Statistical ana-
lysis was carried out with a one-way ANOVA followed by Tukey post-
hoc multiple comparison test using the statistical software GraphPad
Prism.
Axonal transport experiments
Wild type and Dynlrb1tm1c DRG ganglia were dissociated as pre-
viously described and neurons were plated on MatTek glass bottom
dishes (MatTek corporation) in F12 medium (ThermoFisher Scientific)
supplemented with 10 μM cytosine β-D-arabinofuranoside hydro-
chloride (AraC, Sigma-Aldrich, C6645) to inhibit glial proliferation.
Adenovirus5 Cre-GFP was added to the neurons 4 h after plating. 96 h
after infection with the virus, cells were washed in warm HBSS medium
(ThermoFisher Scientific). LysoTracker™ Red DND-99 (ThermoFisher
Scientific) (200 nM concentration) or AlexaFluor555-conjugated HCT
(40 nM) were added to the cells. Neurons were transferred to a a
Fluoview (FV10i, Olympus) automated confocal laser-scanning micro-
scope with built-in incubator chamber and imaged with a 60X water
immersion objective. 120 frames at intervals of 5s between each frame
were taken for every transport movie. Movies were tracked manually
using the Manual Tracking plugin of the ImageJ software; while the
percentage of stationary vs moving carriers was performed on kymo-
graphs generated using the Multi Kymograph plugin of ImageJ.
Statistical analysis was performed with two-way ANOVA using the
statistical software GraphPad Prism.
β-Catenin nuclear accumulation in Dynlrb1+/- DRG neurons
Wild type and Dynlrb1+/- DRG ganglia were dissociated as pre-
viously described and cells were plated on coverslips in F12 medium
(ThermoFisher Scientific). 48 h after plating cells were washed in PBS,
fixed in 4% PFA in PBS for 30 min and immunostained for β−catenin
(1:100 dilution), NFH (1:2,000 dilution) and DAPI as described pre-
viously. Coverslips were then mounted with Flouromount-GTM and
imaged using a confocal laser-scanning microscope (Olympus FV1000,
60x oil-immersion objective Olympus UPLSAPO - NA 1.35). Image
quantification was performed using ImageJ software. Nuclei were
identified using a mask drawn on the DAPI straining and cytoplasm was
masked using the NFH staining. Nuclear and cytoplasmic intensity of
β−catenin was recorded. Statistical analysis was carried out with a
one-way ANOVA followed by Tukey post-hoc multiple comparison test
using the statistical software GraphPad Prism.
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Design and production of AAV shDynlrb1
Design of AAV shRNA constructs was based on AAV-shRNA-ctrl
(addgene, plasmid #85741, (Yu et al., 2015)). sh-Ctrl sequence was
replaced by a sequence targeting Dynlrb1 using the BamHI and XbaI





Purified adeno associated virus (AAV) was produced in HEK 293t
cells (ATCC®), with the AAVpro® Purification Kit (All Serotypes) from
TaKaRa (#6666). For each construct 10 plates (15 cm) were transfected
with 20 μg of DNA (AAV-plasmid containing our construct of interest +
2 helper plasmids for AAV9) using jetPEI® (Polyplus) in DMEM medium
without serum or antibiotics. Medium (DMEM, 20 % FBS, 1 mM sodium
pyruvate, penicillin-streptomycin) was added on the following day to a
final concentration of 10% FBS and extraction was done 3 days post
transfection. Purification was performed according to the manu-
facturers’ instructions (TaKaRa, #6666).
Immunohistochemistry of tissue samples
Tissue samples from muscle, skin, DRGs and sciatic nerve were
harvested and fixed in 4% PFA in PBS (30 min for skin at RT, overnight
at 4°C for muscles, DRG ganglia and sciatic nerve). The tissues were
then washed in PBS and equilibrated in 30% w/v sucrose in PBS, em-
bedded in Optimal Cutting Temperature Compound (O.C.T., Tissue-
Tek®) and finally cryo-sectioned at a thickness ranging from 10-50 μm.
Sections were then re-hydrated in PBS, blocked and permeabilized with
5% goat serum, 1% BSA, 0.1% Triton X-100 in PBS, or donkey serum,
0.1% Triton X-100 in PBS for 1 h and incubated with primary antibody
overnight at 4°C. Sections were then washed 3 times in PBS and in-
cubated for 2 h with secondary antibodies from Jackson
Immunoresearch (Alexa Fluor 647 or Alexa Fluor 488 conjugated,
1:500 dilution in PBS). Slides were then washed in PBS, mounted with
Flouromount-GTM, and imaged using a confocal laser-scanning micro-
scope (Olympus FV1000, 60x oil-immersion objective Olympus
UPLSAPO - NA 1.35).
NMJ plate counting
Gastrocnemius muscles from wild type and RNX3-Dynlrb1-/- mice
were sectioned at a thickness of 50 μm. Staining of the neuromuscular
junction was achieved as previously described by incubation with Alexa
555-α-bungarotoxin (1:1000 dilution). Sections were then imaged
using a confocal laser-scanning microscope (Olympus FV1000, 60x oil-
immersion objective Olympus UPLSAPO - NA 1.35) and the number of
positive NMJ-plate per area were manually counted and normalized by
the area. Statistical analysis was performed with t-test using the sta-
tistical software GraphPad Prism.
Sensory skin innervation
Hind paw skin of wild type and RNX3-Dynlrb1-/- mice was sectioned
at a thickness of 20 μm and immunostained as previously described
with an α-CGRP and α-TUJ1 antibodies. The nuclear counterstaining
DAPI was added to highlight all cells in the tissue. Sections were imaged
using a confocal laser-scanning microscope (Olympus FV1000, 60x oil-
immersion objective Olympus UPLSAPO - NA 1.35). The number of
nerve endings was manually counted and normalized by the area of the
skin. Statistical analysis was performed with t-test using the statistical
software GraphPad Prism.
DRG neuron count
L4 DRGs from wild type and RNX3-Dynlrb1-/- mice were serially
sectioned at a thickness of 20 μm in set of 3. One set for each DRG was
then processed for immunostaining as previously described for α-NFH,
α-CGRP and α-TUJ1 antibody (Terenzio et al., 2018b). NFH and CGRP
positive neurons were manually counted in blind. Statistical analysis
was performed with t-test using the statistical software GraphPad
Prism.
Gene expression analysis by Q-PCR
Wild type DRG ganglia were dissociated as described above and
neurons were plated in F12 medium (ThermoFisher Scientific) supple-
mented with 10 μM cytosine β-D-arabinofuranoside hydrochloride
(AraC, Sigma-Aldrich, C6645) to inhibit glial proliferation. AAV9-
shControl and AAV9-shDynlrb1 viruses were added to the neurons 4 h
after plating. 7 days after infection, cells were washed in PBS and total
RNA was extracted using the Oligotex mRNA Mini Kit (Qiagen). RNA
purity and concentration was determined, and 300 ng of total RNA was
then used to synthesize cDNA using SuperScript III (Invitrogen). Q-PCR
was performed on a ViiA7 System (Applied Biosystems) using PerfeCTa
SYBR Green (Quanta Biosciences, Gaithersburg, USA). Forward/
Reverse primers were designed to span exon-exon junction, and the
RNA was treated with DNase H to avoid false-positives. Amplicon
specificity was verified by melting curve analysis. All Q-PCR reactions
were conducted in technical triplicates and the results were averaged
for each sample, normalized to 18S levels and analyzed using the
comparative ΔΔCt method (Livak and Schmittgen, 2001). The primers
(Mus musculus) that were used are the following:
18S forward: AAACGGCTACCACATCCAAG
18S reverse: CCTCCAATGGATCCTCGTTA
Dynlrb1 forward: CAACCTCATGCACAACTTCATC (exon 3)
Dynlrb1 reverse: TCTGGATCACAATCAGGAAATAGTC (exon 4)
RNA sequencing
Wild type and Dynlrb1+/- DRG ganglia were dissociated as described
above and cells were plated on coverslips in F12 medium
(ThermoFisher Scientific). Cells were washed in PBS at 12, 24 and 48 h
after plating and total RNA was extracted using the Oligotex mRNA
Mini Kit (Qiagen). RNA purity, integrity (RIN>7) and concentration
was determined. Three biological repeats were analyzed for each time
point for each genotype.
RNA-sequencing libraries were prepared using the TrueSeq
Stranded RNA kit (100ng). Libraries were indexed and sequenced by
HiSeq4000 with 75 bp paired-end reads and at least 50M reads were
obtained for each sample. Quality control (QC) was performed on base
qualities and nucleotide composition of sequences, mismatch rate,
mapping rate to the whole genome, repeats, chromosomes, key tran-
scriptomic regions (exons, introns, UTRs, genes), insert sizes, AT/GC
dropout, transcript coverage and GC bias to identify problems in library
preparation or sequencing. Reads were aligned to the latest mouse
mm10 reference genome (GRCm38.75) using the STAR spliced read
aligner (ver 2.4.0). Average input read counts were 66.6M and average
percentage of uniquely aligned reads were 86.3%. Total counts of read-
fragments aligned to known gene regions within the mouse (mm10)
ensembl (GRCm38.80) transcript reference annotation are used as the
basis for quantification of gene expression. Fragment counts were de-
rived using HTSeq program (ver 0.6.0). Genes with minimum of 5
counts for at least half of samples were selected. Filtered count data
were normalized and examined for sequencing bias by PCA, and PC1
and PC2 of sequencing QC (described above) were regressed out.
Differentially expressed transcripts were determined by Bioconductor
package EdgeR (ver 3.14.0) at FDR<0.1. Scripts used in the RNA se-
quencing analyses are available at https://github.com/icnn/
RNAseq-PIPELINE.git. Raw and processed data were deposited within
the Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.
gov/geo), accession number (GSE131455).
The gene list from the 48h time point was filtered according to the
FDR (FDR<0.1, Table S1) and uploaded to the Ingenuity Pathway
Analysis software suite (QIAGEN Bioinformatics). The 10 best high
ranking pathways according to their score (-log(p-values)) were further
evaluated and the WNT – β-catenin pathway selected for validation
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(Table S2).
Intrathecal injection of AAV9 in mice
Intrathecal (IT) injections of adeno associated virus serotype 9
(AAV9) of 5 μl total volume were performed at the lumbar segment L4
using a sterile 10 μl Hamilton microsyringe fitted with a 30 gauge
needle. For all constructs, we obtained titers in the range of 10^12-
10^13 viral genomes/ml, which were used undiluted for intrathecal
injections.
Behavioral profiling
All assays were performed during the “dark” active phase of the
diurnal cycle under dim illumination (∼10 lx); the ventilation system
in the test rooms provided a ∼65 dB white noise background. Every
daily session of testing started with a 2 h habituation period to the test
rooms. A recovery period of at least 1 day was provided between the
different behavioral assays.
Home-cage locomotion test
Wild type and RNX3-Dynlrb1-/- mice were monitored over 72 h
using the InfraMot system (TSE Systems, Germany) in order to in-
vestigate possible alterations of basal motor activity and/or circadian
rhythms. The spatial displacement of body-heat images (infra-red ra-
diation) over time was tracked (Panayotis et al., 2018). The first 24 h
were considered as a habituation phase, while the mouse activity of
following 48 h (2 consecutive dark/light cycles) was calculated. Sta-
tistical analysis was carried out with a one-way ANOVA followed by
Tukey post-hoc multiple comparison test using the statistical software
GraphPad Prism.
Open field
The motility of wild type and RNX3-Dynlrb1-/- mice was assessed in
the open-field arena under 120lx (Panayotis et al., 2018).The total
distance moved (cm), the time spent (wall, corner; s) and mean speeds
(cm/s) were recorded using VideoMot2 (TSE System, Germany) or
Ethovision XT11 (Noldus Information Technology, the Netherlands).
The data were analyzed with the COLORcation software (Dagan et al.,
2016). Statistical analysis was carried out with a one-way ANOVA
followed by Tukey post-hoc multiple comparison test or two-way
ANOVA (for speed and distance) using the statistical software GraphPad
Prism.
Accelerating rotarod
Wild type and RNX3-Dynlrb1-/- mice and wild type mice in-
trathecally injected with AAV9-shControl or AAV9-shDynlrb1 were
tested with the ROTOR-ROD system (83x91x61 - SD. Instruments, San
Diego) for their balance/coordination ability (Crawley, 2008; Marvaldi
et al., 2015). Mice were subjected to 3 trials, with 5 min inter-trial
intervals. Rotarod acceleration was set at 20 rpm in 240 s. Latency to
fall (s) was recorded and the average of the 3 trials was considered.
Statistical analysis was carried out with two-way ANOVA using the
statistical software GraphPad Prism.
Catwalk Gait analysis
Wild type and RNX3-Dynlrb1-/- mice and wild type mice in-
trathecally injected with AAV9-shControl or AAV9-shDynlrb1 were
assessed for their motor/balance coordination using the CatWalk as
previously described (Perry et al., 2012). Motivation was achieved by
placing the home cage at the end of the runway. The test was repeated
3-5 times for each mouse. Data were collected and analyzed using the
Catwalk Ethovision XT11 software (Noldus Information Technology,
The Netherlands). The parameters reported for each animal are the paw
stance, defined as the duration in sec of the contact of the paw with the
glass surface, and the step sequence regularity index, defined as the
number of normal step sequence patterns relative to the total number of
paw placements. Statistical analysis was carried out with a one-way
ANOVA followed by Tukey post-hoc multiple comparison test (Wild
type and RNX3-Dynlrb1-/- mice) or t-test (AAV injected mice) using the
statistical software GraphPad Prism.
Statistical analysis
Analysis of multiple groups was made using the ANOVA method.
The choice between one- or two-way ANOVA was based on the re-
quirements for identification of specific factors’ contribution to statis-
tical differences between groups and were followed by the Tukey and
the Sidak post hoc analysis tests respectively. For 2-groups analyses,
unpaired Student’s t test was used. All analyses were performed using
GraphPad Prism version 7.00 for MacOS (GraphPad Software, La Jolla,
California, USA, https://www.graphpad.com/). The results are ex-
pressed as the mean± standard error of the mean (SEM). All statistical
parameters for specific analyses are reported in the figure legends of the
paper. Statistically significant P-values are shown as ∗p<0.05,
∗∗p<0.01, ∗∗∗p<0.001 and ∗∗∗∗p<0.0001.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2020.104816.
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